secwatch.observer — SEC 8-K summary
======================================

Issuer:     Entrada Therapeutics, Inc. (TRDA)
CIK:        0001689375
Form:       8-K
Filed at:   2022-06-03T23:59:59+00:00
Accession:  0001104659-22-068101
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Entrada Therapeutics stockholders elect three Class I directors, ratify auditor
-------------------------------------------------------------------------------

- Dipal Doshi elected with 16,755,890 votes for, 1,330,767 withheld.
- Kush M. Parmar elected with 13,773,852 votes for, 4,312,805 withheld.
- Mary Thistle elected with 16,751,000 votes for, 1,335,657 withheld.
- Ernst & Young LLP ratified as auditor with 18,307,689 votes for, 0 against.
- All proposals passed; no other matters voted on.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1689375/000110465922068101/0001104659-22-068101-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1689375/000110465922068101/tm2217710d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-068101

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer